Home Business Biogen continued as a buy at UBS despite Aduhelm agreement change with...

Biogen continued as a buy at UBS despite Aduhelm agreement change with Eisai

29
0

Biogen continued as a buy at UBS despite Aduhelm agreement change with Eisai

Previous articleUS warns Russia of consequences of any possible Russian use of chemical weapons By Reuters
Next articleCatrin Drabble promoted to CFO at Cobalt, as Tom Sansone steps down

LEAVE A REPLY

Please enter your comment!
Please enter your name here